3-(2-{4-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl}ethyl)-1-(4-chlorophenyl)urea

Catalog No. :
ACXAXB459
CAS No. :
338792-85-1
Molecular Formula :
C19H20Cl2F3N5O
Molecular Weight :
462.30

IUPAC Name:1-(2-(4-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)ethyl)-3-(4-chlorophenyl)urea

3-(2-{4-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl}ethyl)-1-(4-chlorophenyl)urea structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(2-{4-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl}ethyl)-1-(4-chlorophenyl)urea
IUPAC Name1-(2-(4-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)ethyl)-3-(4-chlorophenyl)urea
Molecular FormulaC19H20Cl2F3N5O
Molecular Weight462.30
SMILESO=C(NCCN1CCN(C2=NC=C(C(F)(F)F)C=C2Cl)CC1)NC3=CC=C(Cl)C=C3
InChI KeyAKCRTHNRSLFLIB-UHFFFAOYSA-N
SynonymN-(4-CHLOROPHENYL)-N'-(2-(4-[3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL]PIPERAZINO)ETHYL)UREA;3-(2-{4-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl}ethyl)-1-(4-chlorophenyl)urea;Urea, N-(4-chlorophenyl)-N'-[2-[4-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-1-piperazinyl]ethyl]-
CAS No.338792-85-1

Synthetic Route by SureRoute

1. ACXAXB459 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXAXB459 route product structure diagram
    ACXAXB459338792-85-1
Inquiry

2. ACXAXB459 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSFLO426 route compound structure diagram
    ACSFLO426132834-59-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXAXB459 route product structure diagram
    ACXAXB459338792-85-1
Inquiry

Comments (0)